# OnCo record btm-3566 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/btm-3566/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "btm-3566" ;
  schema:name "BTM-3566"@en ;
  schema:description "BTM-3566 is an experimental oral small molecule from Bantam Pharmaceutical, in phase 1 trials for relapsed or refractory mature B-cell lymphomas and advanced solid tumours."@en ;
  schema:url <https://onco.cc/drugs/btm-3566/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://bantampharma.com/btm_3566/>, <https://bantampharma.com/>, <https://clinicaltrials.gov/search?intr=BTM-3566> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral small molecule" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/bantam-pharmaceutical/> ;
  onco:trials <https://onco.cc/trials/nct06792734/>, <https://onco.cc/trials/nct07266285/> .